Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Albert Faro"'
Autor:
Alessandro N. Franciosi, April Tanzler, Jodi Goodwin, Pearce G. Wilcox, George M. Solomon, Albert Faro, Noel G. McElvaney, Damian G. Downey, Bradley S. Quon
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Background Increasing awareness of milder presentations of cystic fibrosis (CF) and greater interest in non-CF bronchiectasis are likely to lead to more CF screening by respiratory clinicians. As a result, adults who may not strictly fulfil CF diagno
Externí odkaz:
https://doaj.org/article/6f617089f9e54fb9bd7aabebc4efc679
Autor:
Ethan Dubin, Jane Lowers, Elisabeth P. Dellon, Sarah Hempstead, Albert Faro, Erin Tallarico, Anne Fitzpatrick, William R Hunt, Dio Kavalieratos
Publikováno v:
Journal of Cystic Fibrosis. 22:352-355
Although people living with CF (PLwCF) commonly report pain and other symptoms, little is known regarding their experiences of living with and accessing treatment for burdensome symptoms.PLwCF completed online questionnaires assessing symptom prevale
Autor:
Kathleen J. Ramos, Jennifer S. Guimbellot, Maryam Valapour, Lauren E. Bartlett, Travis Hee Wai, Christopher H. Goss, Joseph M. Pilewski, Albert Faro, Joshua M. Diamond
Publikováno v:
Journal of Cystic Fibrosis. 21:745-752
Autor:
Margaret Rosenfeld, Josh Ostrenga, Elizabeth A. Cromwell, Amalia Magaret, Rhonda Szczesniak, Aliza Fink, Michael S. Schechter, Albert Faro, Clement L. Ren, Wayne Morgan, Don B. Sanders
Publikováno v:
JAMA pediatrics. 176(10)
ImportanceNewborn screening (NBS) for cystic fibrosis (CF) has been universal in the US since 2010, but its association with clinical outcomes is unclear.ObjectiveTo describe the real-world effectiveness of NBS programs for CF in the US on outcomes u
Autor:
Elizabeth A. Cromwell, Joshua S. Ostrenga, Jonathan V. Todd, Alexander Elbert, A. Whitney Brown, Albert Faro, Christopher H. Goss, Bruce C. Marshall
Publikováno v:
Journal of Cystic Fibrosis.
Autor:
Edward McKone, Kathleen J. Ramos, Cecilia Chaparro, Joshua Blatter, Ramsey Hachem, Michael Anstead, Fanny Vlahos, Abby Thaxton, Sarah Hempstead, Thomas Daniels, Michelle Murray, Amparo Sole, Robin Vos, Erin Tallarico, Albert Faro, Joseph M. Pilewski
Publikováno v:
Journal of Cystic Fibrosis.
There is no consensus on the best model of care for individuals with CF to manage the non-pulmonary complications that persist after lung transplant. The CF Foundation virtually convened a group of international experts in CF and lung-transplant care
Autor:
Albert Faro, Elaine Chen, Sarah E. Hempstead, Jessica Goggin, Dio Kavalieratos, Christopher H. Goss, Melissa Basile, Lincy Jojan, Elisabeth P. Dellon, Anna M. Georgiopoulos, Mara R. Hobler
Publikováno v:
J Palliat Med
Background: Individuals with cystic fibrosis (CF) experience symptoms affecting quality of life and may benefit from palliative care (PC). Objectives: To present results of content analysis from open-ended survey questions assessing knowledge and exp
Autor:
Aliza K. Fink, Albert Faro, Joshua S. Ostrenga, Sanja Stanojevic, Alexander Elbert, Anne L. Stephenson, Bradley S. Quon, Christopher H. Goss, Kathleen J. Ramos, Xiayi Ma, Bruce C. Marshall, Jenna Sykes, Kristofer Petren
Publikováno v:
Chest. 160:843-853
Background Understanding how health outcomes differ for patients with advanced cystic fibrosis (CF) lung disease living in the United States compared with Canada has health policy implications. Research Question What are rates of lung transplant (LTx
Autor:
Anne L. Stephenson, Sana Swaleh, Jenna Sykes, Sanja Stanojevic, Xiayi Ma, Bradley S. Quon, Albert Faro, Bruce Marshall, Kathleen J. Ramos, Josh Ostrenga, Alex Elbert, Sameer Desai, Elizabeth Cromwell, Christopher H. Goss
Publikováno v:
Journal of Cystic Fibrosis.
The availability of new diagnostic algorithms for cystic fibrosis (CF), changing population demographics and programs that impact family planning decisions can influence incidence rates. Thus, previously reported incidence rates in Canada and the Uni
Autor:
Kristofer Petren, Albert Faro, Bradley S. Quon, Anne L. Stephenson, Joshua S. Ostrenga, Christopher H. Goss, C. Chaparro, Aliza K. Fink, Sanja Stanojevic, Jenna Sykes, Alexander Elbert, Bruce C. Marshall, Kathleen J. Ramos, Xiayi Ma
Publikováno v:
J Heart Lung Transplant
Previous literature in cystic fibrosis (CF) has shown a 10-year survival gap between Canada and the United States (US). We hypothesized that differential access to and survival after lung transplantation may contribute to the observed gap. The object